Severe maternal and neonatal morbidity or mortality in forceps versus cesarean birth in the second stage of labor: A systematic review and meta‐analysis
International Journal of Gynecology & Obstetrics · 2026-12 · 175 (3) · 1199-1213
DOI: 10.1002/ijgo.71152 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 29.06.2026. Verfasst von Irina I Oltean und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Labor Stage, Second, Obstetrical Forceps, Cesarean Section, Extraction, Obstetrical. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Approximately one in four first‐time mothers reach the second stage of labor but cannot have a spontaneous vaginal birth, necessitating an intervention such as forceps to facilitate birth.
Objective
This study synthesizes evidence comparing severe maternal morbidity (SMM) and neonatal morbidity or mortality (SNMM) following forceps and cesarean birth (CB) in the second stage of labor.
Method
Four databases were searched from database inception to May 30, 2023. Original studies comparing SMM or SNMM among individuals with an attempted forceps birth versus second stage CB were included. Meta‐analyses were conducted using the Mantel–Haenszel random‐effects model and the risk ratio (RR) was used as an effect measure with 95% confidence intervals (CIs).
Results
After screening 945 articles, a total of 13 cohort studies encompassing 52 192 individuals were included. Four studies with 34 131 total individuals provided data on SMM. The incidence of SMM was 2.6% with attempted forceps versus 3.7% with second‐stage CB (pooled RR of 0.83, 95% CI 0.64, 1.07). Six studies with a total of 36 135 individuals provided data on SNMM. The incidence of SNMM was 4.5% with forceps versus 2.1% with second stage CB (pooled RR of 1.34, 95% CI 0.90, 2.00). The evidence is very uncertain about the effect of attempted forceps on SMM and SNMM due to moderate or serious risk of bias, inconsistency, and heterogeneity.
Conclusion
Risks of SMM and SNMM are unclear after forceps and second stage CB and the choice between operative interventions should depend on the clinical scenario. Our study protocol was registered in the International Prospective Register of Systematic Reviews ( PROSPERO ) database (CRD42023387112) on January 2, 2023.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
- Department of Obstetrics and Gynecology, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
- Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden.
ORCID-Profile: Irina I Oltean
Zitieren
APA
Oltean, I. I., Kirubarajan, A., & Muraca, G. M. (2026). Severe maternal and neonatal morbidity or mortality in forceps versus cesarean birth in the second stage of labor: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics, 175(3), 1199-1213. https://doi.org/10.1002/ijgo.71152
Vancouver
Oltean II, Kirubarajan A, Muraca GM. Severe maternal and neonatal morbidity or mortality in forceps versus cesarean birth in the second stage of labor: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics. 2026;175(3):1199-1213. doi:10.1002/ijgo.71152
BibTeX
@article{Oltean2026,
author = {Oltean, Irina I and Kirubarajan, Abirami and Muraca, Giulia M},
title = {Severe maternal and neonatal morbidity or mortality in forceps versus cesarean birth in the second stage of labor: A systematic review and meta‐analysis},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
volume = {175},
number = {3},
pages = {1199--1213},
doi = {10.1002/ijgo.71152}
}
EUVIMED